» Articles » PMID: 32275904

Quantification of Viral and Host Biomarkers in the Liver of Rhesus Macaques: A Longitudinal Study of Zaire Ebolavirus Strain Kikwit (EBOV/Kik)

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2020 Apr 11
PMID 32275904
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Zaire ebolavirus (EBOV) causes Ebola virus disease (EVD), which carries a fatality rate between 25% and 90% in humans. Liver pathology is a hallmark of terminal EVD; however, little is known about temporal disease progression. We used multiplexed fluorescent immunohistochemistry and in situ hybridization in combination with whole slide imaging and image analysis (IA) to quantitatively characterize temporospatial signatures of viral and host factors as related to EBOV pathogenesis. Eighteen rhesus monkeys euthanized between 3 and 8 days post-infection, and 3 uninfected controls were enrolled in this study. Compared with semiquantitative histomorphologic ordinal scoring, quantitative IA detected subtle and progressive features of early and terminal EVD that was not feasible with routine approaches. Sinusoidal macrophages were the earliest cells to respond to infection, expressing proinflammatory cytokine interleukin 6 (IL6) mRNA, which was subsequently also observed in fibrovascular compartments. The mRNA of interferon-stimulated gene-15 (ISG-15), also known as ISG15 ubiquitin like modifier (ISG15), was observed early, with a progressive and ubiquitous hybridization signature involving mesenchymal and epithelial compartments. ISG-15 mRNA was prominent near infected cells, but not in infected cells, supporting the hypothesis that bystander cells produce a robust interferon gene response. This study contributes to our current understanding of early EVD progression and illustrates the value that digital pathology and quantitative IA serve in infectious disease research.

Citing Articles

Hepatic and pulmonary macrophage activity in a mucosal challenge model of Ebola virus disease.

Wanninger T, Saldarriaga O, Arroyave E, Millian D, Comer J, Paessler S Front Immunol. 2024; 15:1439971.

PMID: 39635525 PMC: 11615675. DOI: 10.3389/fimmu.2024.1439971.


Natural history of Ebola virus disease in rhesus monkeys shows viral variant emergence dynamics and tissue-specific host responses.

Normandin E, Triana S, Raju S, Lan T, Lagerborg K, Rudy M Cell Genom. 2024; 3(12):100440.

PMID: 38169842 PMC: 10759212. DOI: 10.1016/j.xgen.2023.100440.


The 3' Untranslated Regions of Ebola Virus mRNAs Contain AU-Rich Elements Involved in Posttranscriptional Stabilization and Decay.

Nelson E, Ross S, Olejnik J, Hume A, Deeney D, King E J Infect Dis. 2023; 228(Suppl 7):S488-S497.

PMID: 37551415 PMC: 10651315. DOI: 10.1093/infdis/jiad312.


Understanding virus-host interactions in tissues.

Speranza E Nat Microbiol. 2023; 8(8):1397-1407.

PMID: 37488255 DOI: 10.1038/s41564-023-01434-7.


Vascular injury is associated with repetitive head impacts and tau pathology in chronic traumatic encephalopathy.

Kirsch D, Shah A, Dixon E, Kelley H, Cherry J, Xia W J Neuropathol Exp Neurol. 2023; 82(2):127-139.

PMID: 36617181 PMC: 9852946. DOI: 10.1093/jnen/nlac122.


References
1.
Honko A, Johnson J, Marchand J, Huzella L, Adams R, Oberlander N . High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona. Sci Rep. 2017; 7(1):5886. PMC: 5517626. DOI: 10.1038/s41598-017-06179-y. View

2.
Diez-Fernandez C, Haberle J . Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder. Expert Opin Ther Targets. 2017; 21(4):391-399. DOI: 10.1080/14728222.2017.1294685. View

3.
Bennett R, Huzella L, Jahrling P, Bollinger L, Olinger Jr G, Hensley L . Nonhuman Primate Models of Ebola Virus Disease. Curr Top Microbiol Immunol. 2017; 411:171-193. DOI: 10.1007/82_2017_20. View

4.
Martinez O, Johnson J, Honko A, Yen B, Shabman R, Hensley L . Ebola virus exploits a monocyte differentiation program to promote its entry. J Virol. 2013; 87(7):3801-14. PMC: 3624207. DOI: 10.1128/JVI.02695-12. View

5.
Okumura A, Pitha P, Yoshimura A, Harty R . Interaction between Ebola virus glycoprotein and host toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1. J Virol. 2009; 84(1):27-33. PMC: 2798428. DOI: 10.1128/JVI.01462-09. View